Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Infusion of High Dose Omeprazole Versus Regular Dose Omeprazole on Recurrent Bleeding After Endoscopic Treatment of Bleeding Peptic Ulcers

NCT00519519 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT00519519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Infusion of High Dose Omeprazole Versus Regular Dose Omeprazole on Recurrent Bleeding After Endoscopic Treatment of Bleeding Peptic Ulcers
Lead sponsor
Singapore General Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
November 30, 2007
Enrollment
126 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding peptic ulcers disease